Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/tid.13404

http://scihub22266oqcxt.onion/10.1111/tid.13404
suck pdf from google scholar
32639598!7361075!32639598
unlimited free pdf from europmc32639598    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32639598      Transpl+Infect+Dis 2020 ; 22 (6): e13404
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • SARS-CoV2 and immunosuppression: A double-edged sword #MMPMID32639598
  • Lai Q; Spoletini G; Bianco G; Graceffa D; Agnes S; Rossi M; Lerut J
  • Transpl Infect Dis 2020[Dec]; 22 (6): e13404 PMID32639598show ga
  • Severe acute respiratory syndrome Coronavirus 2 (SARS-Cov2) outbreak has caused a pandemic rapidly impacting on the way of life of the entire world. This impact in the specific setting of transplantation and immunosuppression has been poorly explored to date. Discordant data exist on the impact of previous coronavirus outbreaks on immunosuppressed patients. Overall, only a very limited number of cases have been reported in literature, suggesting that transplanted patients not necessarily present an increased risk of severe SARS-Cov2-related disease compared to the general population. We conducted a literature review related to the impact of immunosuppression on coronavirus infections including case reports and series describing immunosuppression management in transplant recipients. The role of steroids, calcineurin inhibitors, and mycophenolic acid has been explored more in detail. A point-in-time snapshot of the yet released literature and some considerations in relation to the use of immunosuppression in SARS-Cov2 infected transplant recipients are provided here for the physicians dealing with immunocompromised patients.
  • |*Immunocompromised Host[MESH]
  • |*Transplant Recipients[MESH]
  • |COVID-19/complications/epidemiology/*immunology[MESH]
  • |Calcineurin Inhibitors/pharmacology[MESH]
  • |Cyclosporine/pharmacology[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Immunosuppression Therapy/*adverse effects[MESH]
  • |Kidney Transplantation[MESH]
  • |Male[MESH]
  • |Pandemics[MESH]
  • |SARS-CoV-2[MESH]
  • |Steroids/administration & dosage[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box